(Q45738530)

15 December 2017

title

Interrelationship between Epstein-Barr virus infection in gastric carcinomas and the expression of apoptosis-associated proteins (English)

1 reference

15 December 2017

0 references

Ishii H

1

1 reference

15 December 2017

Gobé G

2

1 reference

15 December 2017

Kawakubo Y

3

1 reference

15 December 2017

Sato Y

4

1 reference

15 December 2017

Ebihara Y

5

1 reference

15 December 2017

publication date

1 February 2001

1 reference

15 December 2017

1 reference

15 December 2017

volume

38

1 reference

15 December 2017

issue

2

1 reference

15 December 2017

page(s)

111-119

1 reference

15 December 2017

cites work

Viruses in human cancers

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2559.2001.01037.X

Impact of HBV, HCV and GBV-C/HGV on hepatocellular carcinomas in Europe: results of a European concerted action

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2559.2001.01037.X

Epstein-Barr virus. Infection and tumour induction

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2559.2001.01037.X

Bcl-2 proto-oncogene expression in Epstein-Barr-virus-associated nasopharyngeal carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2559.2001.01037.X

Epstein-Barr virus and gastric remnant cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2559.2001.01037.X

Burkitt's lymphoma cells are resistant to programmed cell death in the presence of the Epstein-Barr virus latent antigen EBNA-4.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2559.2001.01037.X

Epstein-Barr virus infection is an early event in gastric carcinogenesis and is independent of bcl-2 expression and p53 accumulation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2559.2001.01037.X

Activation of Epstein-Barr virus latent genes protects human B cells from death by apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2559.2001.01037.X

In the absence of Epstein-Barr virus infection, phorbol ester modulates apoptosis in cycloheximide-treated Burkitt's lymphoma (BJA-B) cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2559.2001.01037.X

Bcl-2 is an inner mitochondrial membrane protein that blocks programmed cell death

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2559.2001.01037.X

Apoptotic cell death induced by c-myc is inhibited by bcl-2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2559.2001.01037.X

Low frequency of apoptosis in Epstein-Barr virus-associated gastric carcinoma with lymphoid stroma

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2559.2001.01037.X

Infrequent overexpression of p53 protein in Epstein-Barr virus-associated gastric carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2559.2001.01037.X

Primary central nervous system lymphomas in 72 immunocompetent patients: pathologic findings and clinical correlations. Groupe Ouest Est d'étude des Leucénies et Autres Maladies du Sang (GOELAMS)

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2559.2001.01037.X

Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2559.2001.01037.X

In situ detection of fragmented DNA (TUNEL assay) fails to discriminate among apoptosis, necrosis, and autolytic cell death: a cautionary note

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2559.2001.01037.X

Cancer. p53, guardian of the genome

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2559.2001.01037.X

Mediation of c-Myc-induced apoptosis by p53.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2559.2001.01037.X

The Myc oncoprotein: a critical evaluation of transactivation and target gene regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2559.2001.01037.X

Bcl-2 gene promotes haemopoietic cell survival and cooperates with c-myc to immortalize pre-B cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2559.2001.01037.X

Induction of bcl-2 expression by Epstein-Barr virus latent membrane protein 1 protects infected B cells from programmed cell death

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2559.2001.01037.X

Cooperative interaction between c-myc and bcl-2 proto-oncogenes

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2559.2001.01037.X

What is the value of bcl-2 protein detection for histopathologists?

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2559.2001.01037.X

Coexpression of Bcl-2, c-Myc, and p53 oncoproteins as prognostic discriminants in patients with colorectal carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2559.2001.01037.X

10.1046/J.1365-2559.2001.01037.X

21 January 2018

Identifiers

DOI

1 reference

15 December 2017

1 reference